CD Genomics Unveils Cutting-edge DAP-Seq Service Revealing the Hidden Secrets of DNA

CD Genomics Redefines Genomic Research with Full-Length Transcripts Sequencing (Iso-Seq)

BioIVT to Discuss its Pivotal Role in Liquid Biopsy Research at the AACC Annual Scientific Meeting and Clinical Lab Expo

BioIVT’s standardized collection protocols and diverse donor base help facilitate molecular biomarker validation and ensure their clinical utility.

Insilico Medicine Is Developing New Inhalable Formulation of First Generative AI Drug

On the heels of the announcement of Phase II clinical trials for the first generative AI drug for the devastating lung disease idiopathic pulmonary fibrosis (IPF), clinical-stage drug discovery biotech Insilico Medicine has announced another breakthrough – an inhalation solution for its anti-fibrotic small molecule inhibitor designed to give patients in need another treatment option.

Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis

TVM Capital Life Science together withTillotts Pharma has announced that the companies will jointly invest up to USD 28 million in the newly formed U.S.-based biotechnology company, Mage Biologics Inc.

Absolute Biotech Relaunches SCICONS™ dsRNA Antibodies and ELISA Kits

The gold standard in dsRNA detection now available to virology researchers worldwide

Integrated DNA Technologies Launches New Respiratory Virus Panel

Integrated DNA Technologies is revealing a new next generation sequencing (NGS) solution, the xGen™ Respiratory Virus Amplicon Panel, to support researchers as they combat the challenging diseases of today and prepare for the next pathogen of tomorrow. With 98.7% total genomic coverage of viral respiratory variants Respiratory Syncytial Virus (RSV) A, RSV B, Influenza A H1N1, Influenza A H3N2, Influenza B, and SARS-CoV-2, the uniquely configured single panel is designed to monitor the evolution and spread of these six viruses.

Genedata Announces Licensing Agreement with Gilead Sciences to Enhance Data Science Innovation in Discovery Research

GenHealth.AI Accelerates into Healthcare AI Market with New Funding, Advisor Appointments and Use Cases Across Healthcare

AI Start-up Pioneering Generative AI for Healthcare Receives $13M in Early Funding, Adds Industry Luminaries as Advisors, and Kicks off Use Cases for Health Insurance Plans and Provider Systems

Linus Health Presents New Data on AI-Based Cognitive Assessments at AAIC 2023

Researchers share findings from eight new studies on ability of digital solutions to accelerate early detection of Alzheimer’s and other dementias

Samsung Biologics releases 2023 ESG Report, reaffirming its commitment to net-zero progress and corporate social responsibility

BioIVT Acquires PrecisionMed, a Leading Global Provider of Biospecimens for Neurology and Oncology Research

PrecisionMed developed and manages the largest, private, global repository of longitudinally collected human cerebrospinal fluid (CSF) samples for scientific research.

AARDEX Group Announced as Founder Member of CancerX Initiative to Drive Innovation in the Fight Against Cancer

AARDEX Group Announced as Founder Member of CancerX Initiative to Drive Innovation in the Fight Against Cancer Adherence specialists join multi-stakeholder initiative to improve long-term pathways for cancer patients and meet the challenge of oral treatments.

Adlib + Generis Partnership: A “Game Changer” for Regulated Companies

Generis and Adlib Software have announced the launch of a software connector that provides seamless integration between their industry-leading technology platforms.

PromoCell Launches PromoExQ MSC Growth Medium XF for GMP Compliant Isolation and Expansion of Mesenchymal Stem Cells

PromoCell has announced the launch of PromoExQ MSC Growth Medium XF, a serum- and xeno-free cell culture medium designed for GMP-compliant isolation and expansion of mesenchymal stem cells for cell therapy manufacturing applications.

Vector Laboratories Acquires Quanta BioDesign to Continue Growth Strategy of Strengthening Development and Manufacturing Services for Life Science and Biopharma Customers

Acquisition expands customers' ability to accelerate their advanced bioconjugate and payload delivery design innovation

Cytel acquires French group stève consultants to further expand value evidence and real-world analytics capabilities

Cytel Inc. has acquired stève consultants, specialists in market access, real-world (RWE), and health economics and outcomes research (HEOR).

Endor Labs Recognized as a Cool Vendor in the 2023 Gartner® Cool Vendors™ in Platform Engineering for Scaling Application Security Practices

Startup, Endor Labs has been named a Gartner Cool Vendor in Platform Engineering for Scaling Application Security Practices, highlighting the company’s commitment to providing cutting-edge solutions that address the challenges faced by platform engineering and DevSecOps teams in meeting application security needs.

Inizio Engage launches Patient Access Services – an integrated suite of patient support services to enhance access and adherence for specialty therapies

DoseMe Expands Leadership Team with Appointments of Paul Edwards to CEO, John Hardesky to CCO and Sharmeen Roy to Chief Strategy & Science Officer

DoseMe, a leading provider of precision dosing software for therapeutic drug monitoring and creators of DoseMeRx and DoseMe Analytics, today announced the appointments of Paul Edwards to Chief Executive Officer, John Hardesky to the role of Chief Commercial Officer and Dr. Sharmeen Roy, PharmD, BCPS, to Chief Strategy and Science Officer.